These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13136545)

  • 1. [Proposed new law on pharmacy].
    Ugeskr Laeger; 1953 Nov; 115(47):1745-6. PubMed ID: 13136545
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug sampling: legislation proposed; industry receptive to ending practice.
    Gatty B
    Hosp Formul; 1994 Jun; 29(6):478, 477. PubMed ID: 10134577
    [No Abstract]   [Full Text] [Related]  

  • 3. New law introduces tougher rules on drug regulation in France.
    Benkimoun P
    BMJ; 2011 Dec; 343():d8309. PubMed ID: 22194407
    [No Abstract]   [Full Text] [Related]  

  • 4. [The course of pharmacy legislation and pharmaceutical industry legislation in the German Democratic Republic].
    KRUEGER G
    Pharmazie; 1959 Nov; 14():157-61. PubMed ID: 14412213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Swiss pharmaceutical legislation].
    GIRARDET ME
    Prod Pharm; 1960 Mar; 15():130-1. PubMed ID: 13828130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Permits for patent medicines and the right of transferring them].
    MARTELLIERE E
    Prod Pharm; 1961 Jan; 16():28-9. PubMed ID: 13767279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical legislation in Great Britain].
    GIRARDET E
    Prod Pharm; 1960 Feb; 15():84-6. PubMed ID: 13828129
    [No Abstract]   [Full Text] [Related]  

  • 8. Nevada law aims to halt drug diversion by wholesalers.
    Young D
    Am J Health Syst Pharm; 2002 Jan; 59(2):103-4. PubMed ID: 11826557
    [No Abstract]   [Full Text] [Related]  

  • 9. Bill 102: deal or no deal for big pharma.
    Rasky H
    Health Law Can; 2007 May; 27(4):73-84. PubMed ID: 17580795
    [No Abstract]   [Full Text] [Related]  

  • 10. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacy in Norway].
    Karlsen J
    Pharm Weekbl; 1967 Aug; 102(31):771-4. PubMed ID: 5591081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patent rights in pharmacy].
    Madeuf MC
    Farmaco Prat; 1968 May; 23(5):227-37. PubMed ID: 5712398
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proposal for law on pharmacy. IV. Proprietary drugs].
    Ugeskr Laeger; 1953 Nov; 115(47):1747-52. PubMed ID: 13136546
    [No Abstract]   [Full Text] [Related]  

  • 14. [The "third party" in the pharmaceutical industry].
    Karrer E
    Boll Chim Farm; 1966 Aug; 105(8):563-9. PubMed ID: 6003361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quality control in pharmaceutic industry].
    de Oliveira E
    Hospital (Rio J); 1969 Feb; 75(2):543-61. PubMed ID: 5311212
    [No Abstract]   [Full Text] [Related]  

  • 16. Our future--who will determine it?
    Tiemann KE
    J Am Pharm Assoc; 1976 Jun; 16(6):294-5, 362-3. PubMed ID: 1270741
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of drug substitution is the real issue.
    Stetler CJ
    J Med Soc N J; 1979 Jun; 76(6):458-9. PubMed ID: 287817
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations for developing an antiarrhythmic agent: a perspective from the pharmaceutical industry.
    Antonaccio MJ
    Can J Cardiol; 1994 Apr; 10(3):325-6. PubMed ID: 8162528
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 20. [The responsibility of the pharmaceutical industry].
    Andersen K
    Nord Med; 1975 Apr; 90(4):115. PubMed ID: 1134911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.